Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer

Diagnostic Pathology

Liang-ming Zhang¹  Wei-min Wang¹  Li-ming Chen¹  Liang-liang Dong¹ 

[1] Department of Medical Oncology, Yantai Yuhuangding Hospital, 20 Yuhuangding East Road, Yantai 264000, Shandong, China

关键词: Biomarker;    Prognosis;    Breast cancer;    MicroRNA-124;    MicroRNA;   

Others  :  1214034
DOI  :  10.1186/s13000-015-0257-5

 received in 2014-11-11, accepted in 2015-03-25,  发布年份 2015

【 摘 要 】

Background

MicroRNA-124 (miR-124) has been reported to be downregulated in breast cancer. However, its clinical significance and prognostic value in breast cancer have not been extensively studied.

Methods

The tissue expression levels of miR-124 were measured using quantitative real-time PCR in 133 breast cancer patients. The correlation between the miR-124 levels and the clinicopathological factors of the patients was also analyzed. Survival and Cox proportional-hazards regression analyses were performed to determine the correlation between miR-124 expression levels and prognosis in the patients.

Results

Quantitative real-time PCR analysis showed that miR-124 had lower expression in breast cancer specimens than that in matched adjacent normal breast tissues (0.39 ± 0.16 vs. 1.00 ± 0.39; P < 0.05). Low miR-124 expression level was significantly associated with advanced TNM stage (P = 0.011), lymph node metastasis (P = 0.012), and poorer pathological differentiation (P = 0.023). A significant difference was found that breast cancer patients with low miR-124 expression level had distinctly shorter overall survival than patients with high miR-124 expression level (63.8% vs. 35.2%, P = 0.03). Furthermore, multivariate analysis of the prognosis factors with a Cox proportional hazards model confirmed that low miR-124 expression was a significant independent predictor of poor survival in breast cancer (HR = 3.16, 95% CI: 1.79-9.13, P = 0.017).

Conclusion

These findings proved that the decreased expression of miR-124 might be associated with tumor progression and poor prognosis in patients with breast cancer.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/3752603721493544 webcite

【 授权许可】

   
2015 Dong et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36.
• [2]Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33.
• [3]Li LC. The multifaceted small RNAs. RNA Biol. 2008; 5(2):61-4.
• [4]Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N et al.. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama. 2008; 299(4):425-36.
• [5]Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S et al.. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008; 13(1):48-57.
• [6]Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S et al.. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood. 2007; 109(11):4944-51.
• [7]Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al.. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70.
• [8]Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al.. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005; 334(4):1351-8.
• [9]Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ et al.. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007; 8(10):R214. BioMed Central Full Text
• [10]Lee MR, Kim JS. Kim KS: miR-124a is important for migratory cell fate transition during gastrulation of human embryonic stem cells. Stem Cells. 2010; 28(9):1550-9.
• [11]Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009; 12(4):399-408.
• [12]Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y et al.. MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem. 2013; 31(6):823-32.
• [13]Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K et al.. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene. 2014; 33(4):514-24.
• [14]Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, Kung HJ et al.. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. 2013; 32(35):4130-8.
• [15]Xia J, Wu Z, Yu C, He W, Zheng H, He Y et al.. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol. 2012; 227(4):470-80.
• [16]Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP et al.. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 2012; 61(2):278-89.
• [17]Li L, Luo J, Wang B, Wang D, Xie X, Yuan L et al.. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer. 2013; 12:163. BioMed Central Full Text
• [18]Profumo V, Gandellini P. MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog. 2013; 18(4):341-55.
• [19]Landskroner-Eiger S, Moneke I, Sessa WC. miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect Med. 2013; 3(2):a006643.
• [20]Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle. 2007; 6(17):2127-32.
• [21]Wang S, Li H, Wang J, Wang D. Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn Pathol. 2013; 8:172. BioMed Central Full Text
• [22]Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P et al.. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagn Pathol. 2012; 7:31. BioMed Central Full Text
• [23]Li W, Zang W, Liu P, Wang Y, Du Y, Chen X et al.. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol. 2014; 35(11):10897-904.